Dorota Lemancewicz
Overview
Explore the profile of Dorota Lemancewicz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
127
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gluszynska P, Lemancewicz D, Dzieciol J, Hady H
J Clin Med
. 2021 Dec;
10(24).
PMID: 34945016
The prevalence of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) has considerably increased over the last years. NAFLD is currently the most common cause of chronic liver disease...
2.
Warakomska M, Tynecka M, Lemancewicz D, Grubczak K, Dzieciol J, Moniuszko M, et al.
Oncol Lett
. 2021 Aug;
22(4):728.
PMID: 34429768
Lung cancer represents the most common type of human malignancy and is the main cause of cancer-associated mortality worldwide. To improve the effectiveness of treatment strategies, a better understanding of...
3.
Breczko W, Lemancewicz D, Dzieciol J, Kloczko J, Bolkun L
Adv Med Sci
. 2020 Nov;
66(1):21-27.
PMID: 33246214
Purpose: Proteasome inhibitors (PI) bortezomib or carfilzomib among them, play a crucial role in the modern standard therapy for multiple myeloma (MM). In this study, we intended to evaluate whether...
4.
Bolkun L, Lemancewicz D, Piszcz J, Moniuszko M, Bolkun-Skornicka U, Szkiladz M, et al.
Hematol Oncol
. 2014 Nov;
33(4):199-205.
PMID: 25370722
Tumour necrosis factor-alfa (TNF-α) is an inflammatory cytokine with a wide spectrum of biological activity, including angiogenesis. Tumour necrosis factor-related apoptosis inducing ligand (TRAIL), which belongs to the TNF family...
5.
Piszcz J, Lemancewicz D, Dudzik D, Ciborowski M
Electrophoresis
. 2013 Nov;
34(19):2857-64.
PMID: 24228264
Multiple myeloma (MM) and chronic lymphocytic leukaemia (CLL) are closely related B-cell non-Hodgkin’s lymphomas. MM, a plasma cell malignancy, is the second most common haematopoietic cancer in Western countries, with...
6.
Lemancewicz D, Bolkun L, Mantur M, Semeniuk J, Kloczko J, Dzieciol J
Platelets
. 2013 Jul;
25(3):181-7.
PMID: 23855381
The expression of adhesion molecules and other cell-surface molecules is substantial in the communication between plasma cells and bone marrow microenvironment, and may lead to increased proliferation of myeloma cells....
7.
Lemancewicz D, Bolkun L, Jablonska E, Kulczynska A, Bolkun-Skornicka U, Kloczko J, et al.
Leuk Res
. 2013 Jun;
37(9):1089-93.
PMID: 23768867
B-cell activating factor (BAFF), a proliferation-inducing ligand (APRIL) and apoptosis inducing ligand (TRAIL) are members of the tumour necrosis factor (TNF) family. They are the main survival factors for immature,...
8.
Bolkun L, Galar M, Piszcz J, Lemancewicz D, Kloczko J
Thromb Res
. 2012 Dec;
131(3):e110-3.
PMID: 23269381
The potential role of alterations in protein Z (PZ) concentrations in the pathogenesis of coagulation has been investigated in several studies which, however, yielded conflicting results. Protein Z deficiency may...
9.
Lemancewicz D, Bolkun L, Porowska H, Galar M, Semeniuk J, Kloczko J, et al.
Folia Histochem Cytobiol
. 2012 Jan;
49(4):654-8.
PMID: 22252760
Mucins have been shown to be aberrantly overexpressed in various diseases including cystic fibrosis, asthma, and cancer. Recent studies have uncovered the roles of these mucins in the pathogenesis of...
10.
Lemancewicz D, Bolkun L, Jablonska E, Czeczuga-Semeniuk E, Kostur A, Kloczko J, et al.
Med Sci Monit
. 2011 Dec;
18(1):BR54-59.
PMID: 22207110
Background: Tumor growth in multiple myeloma (MM) is regulated by the cytokine networks which are produced by myeloma cells and the microenvironment of the bone marrow. Interleukin-17 (IL-17) is implicated...